Imprimis NJOF, LLC: Drug Recall

Recall #D-1094-2023 · 08/10/2023

Class III: Low Risk

Recall Details

Recall Number
D-1094-2023
Classification
Class III
Product Type
Drug
Recalling Firm
Imprimis NJOF, LLC
Status
Terminated
Date Initiated
08/10/2023
Location
Ledgewood, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,683 bottles

Reason for Recall

Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

Product Description

Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852 (844)-446-6979, NDC: 71384-311-05.

Distribution Pattern

Nationwide in the US

Other Recalls by Imprimis NJOF, LLC

View all recalls by Imprimis NJOF, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.